CoChat

Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)

Almenara, J, Rosato, R, Grant, S · 2002 · Leukemia

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Interactions between the histone deacetylase inhibitor SAHA (suberoylanilide hydroxamic acid) and the cyclin-dependent kinase (CDK) inhibitor flavopiridol (FP) were examined in human leukemia cells. Simultaneous exposure (24 h) of myelomonocytic leukemia cells (U937) to SAHA (1 microM) and FP (100 nM), which were minimally toxic alone (1.5 +/- 0.5% and 16.3 +/- 0.5% apoptosis respectively), produced a dramatic increase in cell death (ie 63.2 +/- 1.9% apoptotic), reflected by morphology, procaspase-3 and -8 cleavage, Bid activation, diminished DeltaPsi(m), and enhanced cytochrome c release. FP blocked SAHA-mediated up-regulation of p21(CIP1) and CD11b expression, while inducing caspase-dependent Bcl-2 and pRb cleavage. Similar interactions were observed in HL-60 and Jurkat leukemic cells. Enhanced apoptosis in SAHA/FP-treated cells was accompanied by a marked reduction in clonogenic surivival. Ectopic expression of either dominant-negative caspase-8 (C8-DN) or CrmA partially attenuated SAHA/FP-mediated apoptosis (eg 45 +/- 1.5% and 38.2 +/- 2.0% apoptotic vs 78 +/- 1.5% in controls) and Bid cleavage. SAHA/FP induced-apoptosis was unaffected by the free radical scavenger L-N-acetyl cysteine or the PKC inhibitor GFX. Finally, ectopic Bcl-2 expression marginally attenuated SAHA/FP-related apoptosis/cytochrome c release, and failed to restore clonogenicity in cells exposed to these agents. Together, these findings indicate that SAHA and FP interact synergistically to induce mitochondrial damage and apoptosis in human leukemia cells, and suggest that this process may also involve engagement of the caspase-8-dependent apoptotic cascade.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.leu.2402535

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Rosato RR, Almenara JA, Cartee L, Betts V, Chellappan SP, Grant S . The cyclin-dependent kinase inhibitor flavopiridol disrupts butyrate-induced p21CIP1 expression and maturation while enhancing apoptosis in human myeloid leukemia cells MolCancer Ther 2002 1: 253–266

Cited by

See all 151

Metadata

Authors
Almenara, J., Rosato, R., & Grant, S.
Affiliations
Virginia Commonwealth University (US)
Venue
Leukemia
Published
2002-07-01
Volume
16
Issue
7
Pages
1331-1343
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W2331221462
Cited by
141
References
50
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 7 · 2013: 10 · 2012: 4
FWCI
4.05
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Leukemia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Moffitt Cancer Center
  • National Institutes of Health (5r01ca083705-04)
  • National Cancer Institute (CA 83705, CA63753, R01CA063753)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords
flavopiridol, vorinostat, histone deacetylase inhibitors, cyclin-dependent kinase inhibitors, drug synergy, apoptosis, mitochondrial damage, cytochrome c release, caspase-8, Bid, Bcl-2, p21, leukemia cells, U937 cells, HL-60 cells, Jurkat, clonogenic survival, CrmA
MeSH terms
Vorinostat, Antineoplastic Agents, Drug Synergism, Enzyme Inhibitors, Flavonoids, Humans, Hydroxamic Acids, Leukemia, Mitochondria, Piperidines, Apoptosis, Cyclin-Dependent Kinases, HL-60 Cells, Caspases, U937 Cells, Caspase 8, Caspase 9, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.